This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Hsc Research and Development Limited Partnership, University of Toronto. Active years: 2000-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 36 
1 out of 529 
Years Active: 2000-2015
Title: The Innovative Contributions of Derek Van Der Kooy
Introduction
Derek Van Der Kooy is a prominent inventor based in Toronto, Canada. He has made significant contributions to the field of biomedical engineering, particularly in the area of cell delivery systems and retinal stem cell research. With a total of 2 patents, his work has the potential to impact medical treatments and regenerative medicine.
Latest Patents
One of his latest patents is an "Injectable polymer composition for use as a cell delivery vehicle." This invention provides a polymer composition comprising at least one thermal gelling polymer and at least one anionic polymer for cell delivery applications. These injectable polymer compositions are shear-thinning, thixotropic, and resorbable. More specifically, it describes a hyaluronan (HA) and methylcellulose (MC) based thermogelling cell delivery system (HAMC) that promotes cell survival both in vitro and in vivo. Importantly, HAMC enhances the survival of transplanted stem/progenitor cells in the injured central nervous system (CNS) compared to media alone. This hydrogel system has applications for minimally-invasive cell delivery to other tissues and organs in the body as well.
Another significant patent relates to "Retinal stem cells." This invention involves stem cells isolated from the retina of mammals and retinal cells differentiated from these stem cells. It also includes a method of isolating retinal stem cells and inducing them to produce retinal cells. The invention encompasses pharmaceuticals made with retinal stem cells or retinal cells, which may be used to restore vision lost due to diseases or disorders of the retina. Additionally, it includes retinal stem cell and retinal cell culture systems for toxicological assays and for developing tumor cell lines.
Career Highlights
Derek Van Der Kooy has worked with notable institutions, including the University of Toronto and HSC Research and Development Limited Partnership. His research has focused on innovative solutions that bridge the gap between engineering and medicine, particularly in the realm of regenerative therapies.
Collaborations
Throughout his career, he has collaborated with esteemed colleagues such as Molly S. Shoichet and Tasneem Zahir. These collaborations have further enriched his research and contributed to advancements in the field.
Conclusion
Derek Van Der Kooy's innovative work in cell delivery systems and retinal stem cell research showcases his commitment to advancing medical science. His patents reflect a
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile